Wang Y - Search Results

1

Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.

Hu Y, Shi Y, Chen H, Tao M, Zhou X, Li J, Ma X, Wang Y, Liu N. Hu Y, et al. Among authors: wang y. Front Immunol. 2022 Mar 2;13:858494. doi: 10.3389/fimmu.2022.858494. eCollection 2022. Front Immunol. 2022. PMID: 35309342 Free PMC article.

2

Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis.

Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: wang y. Front Pharmacol. 2021 Aug 23;12:724141. doi: 10.3389/fphar.2021.724141. eCollection 2021. Front Pharmacol. 2021. PMID: 34497522 Free PMC article.

3

Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.

Shi Y, Xu L, Tao M, Fang L, Lu J, Gu H, Ma S, Lin T, Wang Y, Bao W, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: wang y. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F488-F505. doi: 10.1152/ajprenal.00234.2018. Epub 2018 Dec 19. Am J Physiol Renal Physiol. 2019. PMID: 30566000 Free PMC article.

4

Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Tao M, Shi Y, Tang L, Wang Y, Fang L, Jiang W, Lin T, Qiu A, Zhuang S, Liu N. Tao M, et al. Among authors: wang y. Am J Physiol Renal Physiol. 2019 Apr 1;316(4):F660-F673. doi: 10.1152/ajprenal.00480.2018. Epub 2019 Jan 16. Am J Physiol Renal Physiol. 2019. PMID: 30648910 Free PMC article.

5

Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.

Shi Y, Tao M, Wang Y, Zang X, Ma X, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: wang y. J Pathol. 2020 Jan;250(1):79-94. doi: 10.1002/path.5352. Epub 2019 Nov 14. J Pathol. 2020. PMID: 31579944 Free PMC article.

6

Peritoneal fibrosis and epigenetic modulation.

Wang Y, Shi Y, Tao M, Zhuang S, Liu N. Wang Y, et al. Perit Dial Int. 2021 Mar;41(2):168-178. doi: 10.1177/0896860820938239. Epub 2020 Jul 14. Perit Dial Int. 2021. PMID: 32662737 Review.

7

Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.

Shi Y, Ni J, Tao M, Ma X, Wang Y, Zang X, Hu Y, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: wang y. Ren Fail. 2020 Nov;42(1):890-901. doi: 10.1080/0886022X.2020.1811119. Ren Fail. 2020. PMID: 32862739 Free PMC article.

8

The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis.

Huang G, Wang Y, Shi Y, Ma X, Tao M, Zang X, Qi Y, Qiao C, Du L, Sheng L, Zhuang S, Liu N. Huang G, et al. Among authors: wang y. J Cell Mol Med. 2021 Sep;25(18):8628-8644. doi: 10.1111/jcmm.16819. Epub 2021 Jul 26. J Cell Mol Med. 2021. PMID: 34309202 Free PMC article.

9

Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.

Shi Y, Li J, Chen H, Hu Y, Tang L, Wang Y, Zang X, Ma X, Huang G, Zhou X, Tao M, Lv Z, Chen S, Qiu A, Zhuang S, Liu N. Shi Y, et al. Among authors: wang y. J Pathol. 2022 Oct;258(2):164-178. doi: 10.1002/path.5987. Epub 2022 Aug 16. J Pathol. 2022. PMID: 35792675

10

Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study.

Ma X, Shi Y, Tao M, Jiang X, Wang Y, Zang X, Fang L, Jiang W, Du L, Jin D, Zhuang S, Liu N. Ma X, et al. Among authors: wang y. BMJ Open. 2020 Feb 13;10(2):e029949. doi: 10.1136/bmjopen-2019-029949. BMJ Open. 2020. PMID: 32060152 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293,675 results

Search Page

Filters